• 1
    Nader-Macías ME, López de Bocanera ME, Silva de Ruiz C, Pesce de Ruiz Holgado A. Isolation of lactobacilli from the urogenital tract of mice. Elaboration of beads for their inoculation. Microbiologie-Aliments-Nutrition 1992; 10: 437
  • 2
    Herthelius M, Gorbach SL, Mollby R, Nord CE, Pettersson L, Winberg J. Elimination of vaginal colonization with E. coli by administration of indigenous flora. Infect Immun 1989; 57: 244751
  • 3
    Redondo-López V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis 1990; 12: 85672
  • 4
    Barbes C, Boris S. Potential role of lactobacilli as prophylactic agents against genital pathogens. Aids Patients Care 1999; 13: 74751
  • 5
    Marteau PR, De Vrese M, Séller CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotic. Am J Clin Nut Sup 2001; 73: 430S436S
  • 6
    Corthier G. Antibiotic-associated diarrhoea: treatments by living organisms given by the oral route (probiotics). In Fuller R ed. Probiotics 2: Applications and Practical Aspects. Chapter 3. London: Chapman & Hall, 1997: 4164
  • 7
    Gibson GR, Saavedra JM, MacFarlane S, MacFarlane GT. Probiotics and intestinal infections. In Fuller R ed. Probiotics 2: Applications and Practical Aspects. Chapter 2. London: Chapman & Hall, 1999: 1039
  • 8
    Reid G, Bruce A, Taylor M. Influence of three days antimicrobial therapy and Lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Therapeutics 1992; 14: 115
  • 9
    McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonize the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000; 49: 54352.
  • 10
    Havenaar R, Ten Brink B, Huis in’t Veld JHJ. Selection of strains for probiotic uses In Fuller R ed. Probiotics. The Scientific Basis. London: Chapman & Hall, 1992: 20924
  • 11
    Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995; 23: 3245
  • 12
    Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 2001; 73 (Suppl): 21153
  • 13
    Salminen S, Deighton MA, Benno Y, Gorbach SL. Lactic acid bacteria in health and disease. In Salminen S, Von Wright A eds. Lactic Acid Bacteria. Microbiology and Functional Aspects. New York: Marcel Dekker Inc, 1993
  • 14
    Dunne C, O'Mahony L, Murphy L et al. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo finding. Am J Clin Nutr 2001; 73 (Suppl.): 386S92S
  • 15
    Silva-Ruiz C, Nader-Macias ME, Lopez-Bocanera ME, Pesce-Ruiz Holgado A. Lactobacillus fermentum administered in suspensions and in agarose beads to mice: a comparative study. Microbiologie-Aliments-Nutrition 1993; 11: 3917
  • 16
    Nader-Macias ME, Silva-Ruiz C, Lopez-Bocanera ME. Pesce-Ruiz Holgado A. Behaviour of lactobacilli on prevention and therapeutic effects on urinary tract infections (UTI) in mice. Anaerobe 1996; 2: 8593.
  • 17
    Silva de Ruiz Nader-Macías ME. Lactobacilli effects on the growth and urinary tract infections (UTI) by Klebsiella in mice. Biol Pharm Bull 2003, in press.
  • 18
    Silva-Ruiz C, Lopez-Bocanera ME, Nader-Macias ME, Pesce-Ruiz Holgado A. Effect of lactobacilli and antibiotics on E. coli urinary infections in mice. Biol Pharm Bull 1996; 19: 8893
  • 19
    Silva de Ruiz Nader-Macías ME. Norfloxacin treatment on E. coli in the urinary tract of mice. Effect of probiotic lactobacilli. Biol Pharm Bull 2003, in press.
  • 20
    Silva de Ruiz C, Rey MR, Ruiz Holgado AA, Nader-Macías ME. Experimental administration of estradiol on the colonization of Lactobacillus fermentum and Escherichia coli in the urogenital tract of mice. Biol Pharm Bull 2001; 24: 127 34
  • 21
    Reid G. Probiotic agents to protect the urogenital tract against infections. Am J Clin Nut 2001; 73 (Suppl.): 437S43S
  • 22
    Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol 1999; 17: 35963
  • 23
    Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotic can resolve urogenital infections. FEMS Imm Med Microbiol 2001; 30: 4952
  • 24
    Koop-Hoolihan L. Prophylactic and therapeutic uses of probiotic: a review. J Am Diet Assoc 2001; 101: 22938
  • 25
    Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Inf Dis 2001; 32: 1567 76
  • 26
    Vaughan EE, Mollet B. Probiotics in the new millennium. Nahrung 1999; 43: 14853
  • 27
    Famularo G, Pieluigi M, Cocía R, Mastroiacovo P, Simone CD. Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Med Hypothesis 2001; 56: 42130